Can combining different risk interventions into a single formulation contribute to improved cardiovascular disease risk reduction? Rationale and design for an international, open-label program to assess the effectiveness of a single pill (amlodipine/atorvastatin) to attain recommended target levels for blood pressure and lipids (The JEWEL Program) 期刊界 All Journals 搜尽天下杂志传播学术成果专业期刊搜索期刊信息化学术搜索

Can combining different risk interventions into a single formulation contribute to improved cardiovascular disease risk reduction? Rationale and design for an international, open-label program to assess the effectiveness of a single pill (amlodipine/atorvastatin) to attain recommended target levels for blood pressure and lipids (The JEWEL Program)

作者姓名：	Hobbs FD,Gensini G,Mancini GB,Manolis AJ,Bauer B,Böhler S,Genest J,Feldman R,Harvey P,Jenssen TG,Metcalfe M,da Silva PM JEWEL Study Group

摘要：
本文献已被 PubMed 等数据库收录！